Steven P. LANGSTON,Edward J. OLHAVA,Stepan VYSKOCIL
申请号：
HK12106507.9
公开号：
HK1166308B
申请日:
2009.04.27
申请国别(地区):
HK
年份:
2017
代理人:
摘要：
This invention relates to compounds of formula (I) that inhibit E1 activating enzymes, pharmaceutical compositions comprising the compounds, and methods of using the compounds. The compounds are useful for treating disorders, particularly cell proliferation disorders, including cancers, inflammatory and neurodegenerative disorders； and inflammation associated with infection and cachexia.
